Display Settings:

Format

Send to:

Choose Destination

    Am J Ophthalmol. 2002 Jan;133(1):159-60.

    Clinical and oculographic response to Tenuate Dospan (diethylpropionate) in a patient with congenital nystagmus.

    Hertle RW, Maybodi M, Mellow SD, Yang D.

    Pediatric Ophthalmology, Strabismus and Eye Movement Service, The Laboratory of Sensorimotor Research, The National Eye Institute, The National Institutes of Health, Bethesda, Maryland, USA. hertler@chi.osu.edu

    PURPOSE: We report a female adult with congenital nystagmus who responded with improved visual function and oculographic parameters after taking the anorexic diet drug Tenuate Dospan (diethylproprionate; Watson Laboratories, Inc., Corona, California). METHODS: Observational case report. Clinical ophthalmic examination and ocular motility recordings were performed before and after administration of the drug Tenuate Dospan. RESULTS: The binocular visual acuity of the patient improved from 20/70 to 20/50, her exotropic deviation decreased from 12 to 4 prism diopters, her stereopsis increased from none to 200 seconds/arc, and her ocular motility recordings showed increased foveation periods and a broadened null zone. CONCLUSION: For unexplained reasons, the anorexic stimulant Tenuate Dospan "paradoxically" improved the nystagmus and binocular function in this patient with congenital nystagmus. This observation may be the basis for investigation of a new pharmacological treatment approach to patients with congenital nystagmus or strabismus.

    PMID: 11755862 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Diethylpropion (Tenuate®, Tenuate Dospan®)

      Diethylpropion decreases appetite. It is used on a short-term basis (a few weeks), in combination with diet, to help you lose weight.